Franz-Werner Haas (Photo by THOMAS KIENZLE / AFP) (Photo by THOMAS KIENZLE/AFP via Getty Images)
March 1, 2022 12:53 PM ESTUpdated 01:53 PM
Pharma
Manufacturing

Cure­Vac es­tab­lish­es RNA print­er-spe­cif­ic com­pa­ny as light at the end of tun­nel nears

Josh Sullivan

When Cure­Vac CEO Franz-Wern­er Haas at­tend­ed the in­au­gur­al mR­NA health con­fer­ence in 2013, there were just 80 peo­ple in at­ten­dance, large­ly from Mod­er­na, BioN­Tech and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

A service from the Financial Times